Synchrony Financial (SYF) is back in focus after announcing a partnership with Figo Pet Insurance that links Figo policies with Synchrony’s CareCredit cards for veterinary payments and reimbursements.
See our latest analysis for Synchrony Financial.
The new pet insurance partnership comes after a mixed period for the stock, with a 3.65% 7 day share price return and a 22.66% 90 day share price decline, alongside a 55.47% 1 year total shareholder return that points to longer term momentum.
If this kind of payment and financing story interests you, it may also be worth scanning other areas of the market using our screener of 20 top founder-led companies
With SYF trading at US$68.42, carrying a value score of 6 and an indicated intrinsic discount of 56.70%, the key question is whether this reflects a genuine mispricing or if the market is already factoring in expectations of future growth.
Most Popular Narrative: 34.8% Undervalued
According to the most followed narrative on Synchrony Financial, a fair value of $105 per share sits well above the recent $68.42 close, setting up a clear tension between modeled value and market pricing.
In plain valuation terms:
Your DCF/Excess Return analysis suggests Synchrony Financial’s intrinsic value is around $145 per share, indicating the stock could be trading at a steep discount (~40% undervalued) versus its fundamental long-term economic profit potential. Current market pricing and consensus analyst targets are significantly lower, around the mid $80s to $100, mainly because of short term earnings expectations and risk pricing. The recent Federal Reserve rate cut is expected to support lending economics and may act as a positive tailwind for SYF’s profitability, but market sentiment and macro risk continue to temper valuation multiples.
Want to see what sits behind that gap between modeled value and today’s price? The narrative focuses on sustained profitability, resilient returns on equity and tightly managed funding costs.
Result: Fair Value of $105 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, you still need to keep an eye on consumer credit stress and potential regulatory shifts around fees, as these could pressure returns and weaken the undervaluation case.
Find out about the key risks to this Synchrony Financial narrative.
Next Steps
With both clear risks and meaningful upside arguments on the table, it makes sense to move quickly and test the narrative against the numbers yourself. Start by weighing up the 6 key rewards and 3 important warning signs
Looking for more investment ideas?
If you stop here, you risk missing other opportunities that could fit your style, so take a few minutes to scan fresh stock ideas tailored to different priorities.
- Target steady compounding by reviewing companies built around consistent shareholder payouts through the 13 dividend fortresses.
- Zero in on quality at a discount by checking the 58 high quality undervalued stocks that combine fundamentals with value focused pricing.
- Dial back volatility by assessing companies flagged in the 67 resilient stocks with low risk scores where business stability and risk scores sit at the centre of the screen.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com